Advanced

Does disease activity at start of biologic therapy influence work-loss in RA patients?

Olofsson, Tor O LU ; Johansson, Kari; Eriksson, Jonas K; van Vollenhoven, Ronald; Miller, Heather; Petersson, Ingemar LU ; Askling, Johan and Neovius, Martin (2015) In Rheumatology (Oxford, England)
Abstract
To compare work-loss in RA patients starting their first biologic with high vs moderate disease activity.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Rheumatology (Oxford, England)
publisher
Oxford University Press
external identifiers
  • PMID:26683196
  • Scopus:84963772362
ISSN
1462-0332
DOI
10.1093/rheumatology/kev407
language
English
LU publication?
yes
id
e25d853b-6575-4eb6-b805-0ccdedcf1159 (old id 8504275)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26683196?dopt=Abstract
date added to LUP
2016-01-05 21:36:17
date last changed
2016-11-14 09:42:42
@misc{e25d853b-6575-4eb6-b805-0ccdedcf1159,
  abstract     = {To compare work-loss in RA patients starting their first biologic with high vs moderate disease activity.},
  author       = {Olofsson, Tor O and Johansson, Kari and Eriksson, Jonas K and van Vollenhoven, Ronald and Miller, Heather and Petersson, Ingemar and Askling, Johan and Neovius, Martin},
  issn         = {1462-0332},
  language     = {eng},
  month        = {12},
  publisher    = {ARRAY(0xa622790)},
  series       = {Rheumatology (Oxford, England)},
  title        = {Does disease activity at start of biologic therapy influence work-loss in RA patients?},
  url          = {http://dx.doi.org/10.1093/rheumatology/kev407},
  year         = {2015},
}